ロード中...
A Designer Bleomycin with Significantly Improved DNA Cleavage Activity
The bleomycins (BLMs) are used clinically in combination with a number of other agents for the treatment of several types of tumors, and the BLM, etoposide, and cisplatin treatment regimen cures 90–95% of metastatic testicular cancer patients. BLM-induced pneumonitis is the most feared, dose-limitin...
保存先:
| 主要な著者: | , , , , , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2012
|
| 主題: | |
| オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3422780/ https://ncbi.nlm.nih.gov/pubmed/22831455 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1021/ja3056535 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|